Gregory Wang

发表

Durability of antibody responses and frequency of clinical and subclinical SARS-CoV-2 infection six months after BNT162b2 COVID-19 vaccination in healthcare workers

W. Wang, C. Broder, R. Vassell, 2021, medRxiv.

Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection

C. Broder, S. Pollett, T. Burgess, 2022, PloS one.

Post-vaccination Omicron infections induce broader immunity across antigenic space than prototype mRNA COVID-19 booster vaccination or primary infection

Rupal M Mody, C. Broder, B. Agan, 2022, bioRxiv.

Prospective Assessment of Symptoms to Evaluate Asymptomatic SARS-CoV-2 Infections in a Cohort of Health Care Workers

C. Broder, K. Bishop-Lilly, R. Cer, 2022, Open forum infectious diseases.

SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster

Rupal M Mody, C. Broder, B. Agan, 2021, bioRxiv.

Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history

C. Broder, B. Agan, L. Katzelnick, 2022, Cell Host & Microbe.

Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers

C. Broder, J. Powers, A. Snow, 2021, Open forum infectious diseases.

SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum, but evades most convalescent serum and therapeutic antibodies

C. Broder, B. Agan, L. Katzelnick, 2022, Science Translational Medicine.

Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers

C. Broder, R. Vassell, C. Weiss, 2022, Emerging infectious diseases.

Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability

C. Broder, S. Anderson, S. Pollett, 2023, Frontiers in immunology.